483
ULTRAVISION CORPORATIONULTRAVISION CORPORATION – FDA 483, May 20, 2022
Record Details
An FDA inspection of ULTRAVISION CORPORATION in North Palm Beach, FL, revealed significant deficiencies across its quality system. The firm failed to establish adequate procedures for design control, quality audits, management review, training, MDR reporting, complaint handling, and purchasing controls. These issues indicate a broad lack of adherence to regulatory requirements for medical device manufacturing.
View Company Profile
ID · 1c4927b3-4925-4633-adc2-9a61d76d52e6
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.